Martin Shkreli, born in Brooklyn, New York, in 1982, began his career in the world of finance. After graduating from Baruch College with a degree in business administration, he started his first hedge fund, Elea Pharmaceuticals, at the age of 22. This was the beginning of his journey into the pharmaceutical industry, a sector he would later make headlines in.

Shkreli’s rise to fame began with his second hedge fund, MSMB Capital Management, which he founded in 2009. Here, he gained a reputation for his aggressive and unconventional investment strategies, often short-selling pharmaceutical stocks. His bold moves caught the attention of the media, and he became known as a controversial figure in the financial world. However, it was his role as the CEO of Turing Pharmaceuticals that catapulted him into the public eye.

Martin Shkreli’s Current Net Worth in 2025

As of 2025, Martin Shkreli’s estimated net worth is $50 million. This figure takes into account his business ventures, investments, and legal settlements.

Career

Martin Shkreli, often referred to as the “Pharma Bro,” is a controversial figure in the pharmaceutical industry. He founded Turing Pharmaceuticals in 2014, where he gained notoriety for increasing the price of Daraprim, a life-saving drug, by 5,000%. Before Turing, he was the CEO of Retrophin, another pharmaceutical company. His career began at the age of 17 when he interned at Cramer, Rosenthal & McGlynn, an investment firm.

Other Ventures

In addition to his pharmaceutical companies, Shkreli has been involved in various other ventures. He founded MSMB Capital Management, a hedge fund, in 2009. He also started a social media platform called Druglike, which was designed to connect pharmaceutical companies with investors. Currently, he is involved in a webcast called “The Dose,” where he discusses pharmaceutical industry news and trends.

Assets

Shkreli’s assets primarily consist of his stakes in pharmaceutical companies and his real estate holdings. He owns a $1.4 million mansion in Montclair, New Jersey, and a $4.6 million apartment in New York City. He also has a significant investment in KaloBios Pharmaceuticals, a company he acquired in 2015. His art collection, which includes a one-of-a-kind Wu-Tang Clan album, is also a notable asset.

Annual Income

Shkreli’s annual income has varied significantly throughout his career. In 2014, his salary as the CEO of Turing Pharmaceuticals was reported to be $10 million. However, his income has been impacted by legal issues in recent years. In 2017, he was convicted for securities fraud and sentenced to seven years in prison. His annual income since then has been significantly lower, primarily due to his inability to manage his businesses while incarcerated.

Frequently Asked Questions about  Shkreli

Frequently Asked Questions: Shkreli Net Worth

1. What is Martin Shkreli’s net worth?

Martin Shkreli’s net worth is estimated to be around $70 million.

2. How did Martin Shkreli make his money?

Shkreli made his fortune through pharmaceutical companies he founded, such as Retrophin and Turing Pharmaceuticals. He is also known for his hedge fund, MSMB Capital Management.

3. What is Martin Shkreli’s most controversial action?

Shkreli’s most controversial action was increasing the price of Daraprim, a life-saving drug, by 5,000% overnight when he was the CEO of Turing Pharmaceuticals.

4. Has Martin Shkreli been convicted of any crimes?

Yes, Shkreli was convicted in 2017 for securities fraud related to his hedge fund and a pharmaceutical company he founded. He was sentenced to seven years in prison.

5. What is Martin Shkreli’s education background?

Shkreli graduated from Baruch College with a degree in business administration. He is not a medical doctor, despite sometimes referring to himself as “Dr. Shkreli.”

6. Why is Martin Shkreli often referred to as “Pharma Bro”?

Shkreli earned the nickname “Pharma Bro” due to his brash and arrogant public persona, as well as his controversial actions in the pharmaceutical industry.

7. What is Martin Shkreli’s involvement with the Wu-Tang Clan?

Shkreli bought the sole copy of the Wu-Tang Clan’s album “Once Upon a Time in Shaolin” for $2 million in 2015. The album was sold as a single copy to raise money for charity.

8. Has Martin Shkreli written any books?

Yes, Shkreli has written a book titled “From Mom’s Basement to the Boardroom: A Wall Street Story.” It was published in 2014.

9. What is Martin Shkreli’s current status?

As of 2022, Shkreli is serving his prison sentence at a federal correctional institution in Pennsylvania.

10. Are there any documentaries or movies about Martin Shkreli?

Yes, there is a documentary called “The Creepy Guy Who Bought Wu-Tang Clan’s Album” that focuses on Shkreli’s life and controversies. Additionally, a biographical film about Shkreli is in development, with Michael C. Hall set to play the lead role.